ARCHIVES

NCI, MABCO Publish Clinical Trials Web Site

This article is from The Cancer Letter archive.

Vol. 22 No. 34 | September 6, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

February 14, 2014

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001